Arsenic Trioxide and Radiation Enhance Apoptotic Effects in HL-60 Cells Through Increased ROS Generation and Regulation of JNK and P38 MAPK Signaling Pathways
Overview
Molecular Biology
Pharmacology
Affiliations
The induction of apoptotic cell death is a significant mechanism of tumor cells under the influence of radio-/chemotherapy, and resistance to these treatments has been linked to some cancer cell lines with a low propensity for apoptosis. The present study aimed to investigate the enhanced effects and mechanisms in apoptosis and the cycle distribution of HL-60 cells, a human leukemia cell line lacking a functional p53 protein, after combination treatment with arsenic trioxide (ATO) and irradiation (IR). Our results indicated that combined treatment led to increased cytotoxicity and apoptotic cell death in HL-60 cells, which was correlated with the activation of cdc-2 and increased expression of cyclin B, the induction of intracellular reactive oxygen species (ROS) generation, the loss of mitochondria membrane potential, and the activation of caspase-3. The combined treatment of HL-60 cells pre-treated with Z-VAD or NAC resulted in a significant reduction in apoptotic cells. In addition, activation of JNK and p38 MAPK may be involved in combined treatment-mediated apoptosis. The data suggest that a combination of IR and ATO could be a potential therapeutic strategy against p53-deficient leukemia cells.
Morino Y, Sugiyama H, Yamane K, Kikuchi M, Yamanaka T, Honda K Oncol Rep. 2024; 52(2).
PMID: 38963046 PMC: 11240863. DOI: 10.3892/or.2024.8768.
Exploiting cell death and tumor immunity in cancer therapy: challenges and future directions.
Lu J, He R, Liu Y, Zhang J, Xu H, Zhang T Front Cell Dev Biol. 2024; 12:1416115.
PMID: 38887519 PMC: 11180757. DOI: 10.3389/fcell.2024.1416115.
Allegra A, Mirabile G, Caserta S, Stagno F, Russo S, Pioggia G Antioxidants (Basel). 2024; 13(4).
PMID: 38671909 PMC: 11047441. DOI: 10.3390/antiox13040461.
P38 MAPK and Radiotherapy: Foes or Friends?.
Garcia-Flores N, Jimenez-Suarez J, Garnes-Garcia C, Fernandez-Aroca D, Sabater S, Andres I Cancers (Basel). 2023; 15(3).
PMID: 36765819 PMC: 9913882. DOI: 10.3390/cancers15030861.
Chandraprabha Vineetha R, Hariharan S, Jaleel A, Chandran M, Harikumaran Nair R Front Oncol. 2020; 10:65.
PMID: 32154163 PMC: 7047343. DOI: 10.3389/fonc.2020.00065.